Cite

HARVARD Citation

    Le Gars, M. et al. (2022). Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine. Immunological reviews. 310 (1), pp. 47-60. [Online]. 
  
Back to record